Temporally Distinct Post-replicative Repair Mechanisms Fill PRIMPOL-dependent SsDNA Gaps in Human Cells
Overview
Authors
Affiliations
PRIMPOL repriming allows DNA replication to skip DNA lesions, leading to ssDNA gaps. These gaps must be filled to preserve genome stability. Using a DNA fiber approach to directly monitor gap filling, we studied the post-replicative mechanisms that fill the ssDNA gaps generated in cisplatin-treated cells upon increased PRIMPOL expression or when replication fork reversal is defective because of SMARCAL1 inactivation or PARP inhibition. We found that a mechanism dependent on the E3 ubiquitin ligase RAD18, PCNA monoubiquitination, and the REV1 and POLζ translesion synthesis polymerases promotes gap filling in G2. The E2-conjugating enzyme UBC13, the RAD51 recombinase, and REV1-POLζ are instead responsible for gap filling in S, suggesting that temporally distinct pathways of gap filling operate throughout the cell cycle. Furthermore, we found that BRCA1 and BRCA2 promote gap filling by limiting MRE11 activity and that simultaneously targeting fork reversal and gap filling enhances chemosensitivity in BRCA-deficient cells.
Molecular dependencies and genomic consequences of a global DNA damage tolerance defect.
de Groot D, Spanjaard A, Shah R, Kreft M, Morris B, Lieftink C Genome Biol. 2024; 25(1):323.
PMID: 39741332 PMC: 11687044. DOI: 10.1186/s13059-024-03451-z.
CAF-1 promotes efficient PrimPol recruitment to nascent DNA for single-stranded DNA gap formation.
Straka J, Khatib J, Pale L, Nicolae C, Moldovan G Nucleic Acids Res. 2024; 52(22):13865-13880.
PMID: 39558157 PMC: 11662685. DOI: 10.1093/nar/gkae1068.
Ravindranathan R, Somuncu O, da Costa A, Mukkavalli S, Lamarre B, Nguyen H Proc Natl Acad Sci U S A. 2024; 121(47):e2413954121.
PMID: 39546575 PMC: 11588084. DOI: 10.1073/pnas.2413954121.
Pale L, Khatib J, Nusawardhana A, Straka J, Nicolae C, Moldovan G Nucleic Acids Res. 2024; 52(22):13832-13848.
PMID: 39530221 PMC: 11662931. DOI: 10.1093/nar/gkae998.
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.
Khalizieva A, Moser S, Bouwman P, Jonkers J Genes Dev. 2024; 39(1-2):86-108.
PMID: 39510841 PMC: 11789497. DOI: 10.1101/gad.352083.124.